The Angelina effect: immediate reach, grasp, and impact of going public

Background:In May 2013, Angelina Jolie revealed in a New York Times opinion piece that she had undergone a preventive double mastectomy because she had a family history of cancer and carried a rare mutation of the BRCA1 gene. Media coverage has been extensive, but it is not obvious what messages the public took from this personal health story.Methods:We conducted a survey with a representative national online panel of 2,572 adults. Participants described their awareness and identified information sources for the Angelina Jolie news story. They also reported their understanding, reactions, perceptions, and subsequent activities related to the story. We asked questions pertaining to personal and societal breast cancer risk and hypothetical questions regarding preventive surgery if the respondent or a family member were in the same position as Ms Jolie. Demographic information was collected, as was family risk for breast and ovarian cancer, and a gauge of numeracy.Results:While three of four Americans were aware of Angelina Jolie’s double mastectomy, fewer than 10% of respondents had the information necessary to accurately interpret Ms Jolie’s risk of developing cancer relative to a woman unaffected by the BRCA gene mutation. Awareness of the Angelina Jolie story was not associated with improved understanding.Conclusion:While celebrities can bring heightened awareness to health issues, there is a need for these messages to be accompanied by more purposeful communication efforts to assist the public in understanding and using the complex diagnostic and treatment information that these stories convey.Genet Med 16 7, 516–521.

[1]  A. Kavanagh,et al.  Use of breast cancer screening and treatment services by Australian women aged 25-44 years following Kylie Minogue's breast cancer diagnosis. , 2008, International journal of epidemiology.

[2]  Lisa M. Schwartz,et al.  The Role of Numeracy in Understanding the Benefit of Screening Mammography , 1997, Annals of Internal Medicine.

[3]  Lisa M. Schwartz,et al.  Celebrity endorsements of cancer screening. , 2005, Journal of the National Cancer Institute.

[4]  Mark A. Kutner,et al.  The Health Literacy of America's Adults: Results from the 2003 National Assessment of Adult Literacy. NCES 2006-483. , 2006 .

[5]  S. Cummings,et al.  NSGC Practice Guideline: Risk Assessment and Genetic Counseling for Hereditary Breast and Ovarian Cancer , 2013, Journal of Genetic Counseling.

[6]  Simon Chapman,et al.  Impact of news of celebrity illness on breast cancer screening: Kylie Minogue's breast cancer diagnosis , 2005, The Medical journal of Australia.

[7]  N Risch,et al.  Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction , 1994, Cancer.

[8]  William J. Brown,et al.  Media Celebrities and Public Health: Responses to 'Magic' Johnson's HIV Disclosure and Its Impact on AIDS Risk and High-Risk Behaviors , 1995 .

[9]  D. Evans,et al.  International variation in physicians' attitudes towards prophylactic mastectomy - comparison between France, Germany, the Netherlands and the United Kingdom. , 2013, European journal of cancer.

[10]  J. Hopper,et al.  Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. , 2003, American journal of human genetics.

[11]  Jan Lubinski,et al.  International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers , 2008, International journal of cancer.

[12]  S. Coughlin,et al.  Population-Based Estimates of the Prevalence of Family History of Cancer among Women , 2002, Public Health Genomics.

[13]  S. Dentzer.  Communicating medical news--pitfalls of health care journalism. , 2009, The New England journal of medicine.

[14]  Gary Kreps,et al.  The Impact of Communication on Cancer Risk, Incidence, Morbidity, Mortality, and Quality of Life , 2003, Health communication.

[15]  M. Cowen,et al.  The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect. , 2003, Archives of internal medicine.

[16]  J. Niederdeppe.  Beyond Knowledge Gaps: Examining Socioeconomic Differences in Response to Cancer News , 2008 .

[17]  J. Gerberding,et al.  Genetic testing for breast and ovarian cancer susceptibility: evaluating direct-to-consumer marketing--Atlanta, Denver, Raleigh-Durham, and Seattle, 2003. , 2004, MMWR. Morbidity and mortality weekly report.

[18]  Cheryl L. L. Carling,et al.  Medical messages in the media – barriers and solutions to improving medical journalism , 2003, Health expectations : an international journal of public participation in health care and health policy.

[19]  Diana Eccles,et al.  Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. , 2013, Journal of the National Cancer Institute.

[20]  Melissa L. Finucane,et al.  Impact of direct-to-consumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: A naturally-occurring experiment , 2005, Genetics in Medicine.

[21]  B. Rimer,et al.  Relationships among breast cancer perceived absolute risk, comparative risk, and worries. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[22]  M. Gail,et al.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.

[23]  J. Goodwin,et al.  Effect of Nancy Reagan's mastectomy on choice of surgery for breast cancer by US women. , 1998, JAMA.

[24]  T. McKenna,et al.  Blurring Personal Health and Public Priorities: An Analysis of Celebrity Health Narratives in the Public Sphere , 2014, Health communication.

[25]  D. Bowen,et al.  Socioeconomic Influences on the Effects of a Genetic Testing Direct-to-Consumer Marketing Campaign , 2009, Public Health Genomics.